86.28
86.28 (0%)
As of Apr 17, 2025
Lemaitre Vascular Inc [LMAT]
Source:
Company Overview
LeMaitre Vascular is a global provider of medical devices and human tissue cryopreservation services largely used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons.
| Country | United States |
| Headquarters | burlington, massachusetts |
| Phone Number | 781-221-2266 |
| Industry | manufacturing |
| CEO | George W. Lemaitre |
| Website | www.lemaitre.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $219.9 |
| Operating Profit | $52.3 |
| Net Income | $44 |
| Net Cash | $1.3 |
Profit Ratios
| Gross Margin | $150.9 |
| Operating Margin | 23.8 |
| Profit as % of Revenues | 342.7% |
| Profit as % of Assets | 9.8% |
| Profit as % of Stockholder Equity | 13.1% |
Management Effectiveness
| Return on Equity | 13.1% |
| Return on Assets | 8% |
| Turnover Ratio | 48.9% |
| EBITA | $52.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $551.8 |
| Total Liabilities | $214.5 |
| Operating Cash Flow | $44.1 |
| Investing Cash Flow | $-200.1 |
| Financing Cash Flow | $158.1 |
